XML 54 R41.htm IDEA: XBRL DOCUMENT v3.3.1.900
SUPPLEMENTAL CONDENSED CONSOLIDATING FINANCIAL INFORMATION CF (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Condensed Financial Statements, Captions [Line Items]        
Net cash provided by (used in) operating activities     $ 55,684 $ 162,410
Capital expenditures $ (196,376) $ (197,166) (343,365) (499,285)
Proceeds from asset dispositions 3,045 6,717 19,152 404,361
Proceeds from sale of unconsolidated affiliates     0 4,185
Net cash provided by (used in) investing activities     (324,213) (90,739)
Proceeds from borrowings     910,421 347,860
Repayment of debt     (567,121) (373,169)
Dividends paid     (35,627) (33,935)
Increases (decreases) in cash related to intercompany advances and debt     0 0
Partial prepayment of put/call obligation     (42) (46)
Acquisition of noncontrolling interest     (7,311) (3,170)
Dividends paid to noncontrolling interest     (153) 0
Payment of contingent consideration     (8,000) 0
Repurchase of Common Stock   (37,400) 0 (80,831)
Issuance of Common Stock     0 2,217
Tax benefit related to stock-based compensation     44 1,642
Net cash provided by (used in) financing activities     292,211 (139,432)
Effect of exchange rate changes on cash and cash equivalents     4,080 (15,214)
Net increase (decrease) in cash and cash equivalents     27,762 (82,975)
Cash and cash equivalents at beginning of period     104,146 204,341
Cash and cash equivalents at end of period 131,908 121,366 131,908 121,366
Parent Company        
Condensed Financial Statements, Captions [Line Items]        
Net cash provided by (used in) operating activities     (111,132) (88,788)
Capital expenditures     (24,633) (38,303)
Proceeds from asset dispositions     0 0
Proceeds from sale of unconsolidated affiliates       0
Net cash provided by (used in) investing activities     (24,633) (38,303)
Proceeds from borrowings     893,025 346,500
Repayment of debt     (542,900) (363,872)
Dividends paid     (35,627) (33,935)
Increases (decreases) in cash related to intercompany advances and debt     (178,140) 255,878
Partial prepayment of put/call obligation     (42) (46)
Acquisition of noncontrolling interest     0 0
Dividends paid to noncontrolling interest     0  
Payment of contingent consideration     0  
Repurchase of Common Stock       (80,831)
Issuance of Common Stock       2,217
Tax benefit related to stock-based compensation     44 1,642
Net cash provided by (used in) financing activities     136,360 127,553
Effect of exchange rate changes on cash and cash equivalents     0 0
Net increase (decrease) in cash and cash equivalents     595 462
Cash and cash equivalents at beginning of period     126 4,640
Cash and cash equivalents at end of period 721 5,102 721 5,102
Guarantor Subsidiaries        
Condensed Financial Statements, Captions [Line Items]        
Net cash provided by (used in) operating activities     104,553 263,933
Capital expenditures     (258,365) (303,951)
Proceeds from asset dispositions     15,192 209,523
Proceeds from sale of unconsolidated affiliates       0
Net cash provided by (used in) investing activities     (243,173) (94,428)
Proceeds from borrowings     0 0
Repayment of debt     0 0
Dividends paid     0 0
Increases (decreases) in cash related to intercompany advances and debt     138,564 (169,111)
Partial prepayment of put/call obligation     0 0
Acquisition of noncontrolling interest     0 0
Dividends paid to noncontrolling interest     0  
Payment of contingent consideration     0  
Repurchase of Common Stock       0
Issuance of Common Stock       0
Tax benefit related to stock-based compensation     0 0
Net cash provided by (used in) financing activities     138,564 (169,111)
Effect of exchange rate changes on cash and cash equivalents     0 0
Net increase (decrease) in cash and cash equivalents     (56) 394
Cash and cash equivalents at beginning of period     884 0
Cash and cash equivalents at end of period 828 394 828 394
Non-Guarantor Subsidiaries        
Condensed Financial Statements, Captions [Line Items]        
Net cash provided by (used in) operating activities     62,263 (13,181)
Capital expenditures     (60,367) (157,031)
Proceeds from asset dispositions     3,960 194,838
Proceeds from sale of unconsolidated affiliates       4,185
Net cash provided by (used in) investing activities     (56,407) 41,992
Proceeds from borrowings     17,396 1,360
Repayment of debt     (24,221) (9,297)
Dividends paid     0 0
Increases (decreases) in cash related to intercompany advances and debt     39,576 (86,767)
Partial prepayment of put/call obligation     0 0
Acquisition of noncontrolling interest     (7,311) (3,170)
Dividends paid to noncontrolling interest     (153)  
Payment of contingent consideration     (8,000)  
Repurchase of Common Stock       0
Issuance of Common Stock       0
Tax benefit related to stock-based compensation     0 0
Net cash provided by (used in) financing activities     17,287 (97,874)
Effect of exchange rate changes on cash and cash equivalents     4,080 (15,214)
Net increase (decrease) in cash and cash equivalents     27,223 (84,277)
Cash and cash equivalents at beginning of period     103,136 200,147
Cash and cash equivalents at end of period 130,359 115,870 130,359 115,870
Consolidations, Eliminations        
Condensed Financial Statements, Captions [Line Items]        
Net cash provided by (used in) operating activities     0 446
Capital expenditures     0 0
Proceeds from asset dispositions     0 0
Proceeds from sale of unconsolidated affiliates       0
Net cash provided by (used in) investing activities     0 0
Proceeds from borrowings     0 0
Repayment of debt     0 0
Dividends paid     0 0
Increases (decreases) in cash related to intercompany advances and debt     0 0
Partial prepayment of put/call obligation     0 0
Acquisition of noncontrolling interest     0 0
Dividends paid to noncontrolling interest     0  
Payment of contingent consideration     0  
Repurchase of Common Stock       0
Issuance of Common Stock       0
Tax benefit related to stock-based compensation     0 0
Net cash provided by (used in) financing activities     0 0
Effect of exchange rate changes on cash and cash equivalents     0 0
Net increase (decrease) in cash and cash equivalents     0 446
Cash and cash equivalents at beginning of period     0 (446)
Cash and cash equivalents at end of period $ 0 $ 0 $ 0 $ 0